Humana Inc is a healthcare plans business based in the US. Humana shares (HUM) are listed on the NYSE and all prices are listed in US Dollars. Humana employs 43,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Humana
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – HUM – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- HUM shares summary
- Compare share dealing platforms
- Is HUM stock a buy or sell?
- Stock performance over time
- Can I short HUM shares?
- Is HUM suitable for ethical investing?
- Are HUM shares over-valued?
- Humana's financials
- How volatile are HUM shares?
- Does Humana pay a dividend?
- Have HUM shares ever split?
- Other common questions
Humana stock price (NYSE: HUM)Use our graph to track the performance of HUM stocks over time.
Humana shares at a glance
|Latest market close||$426.33|
|52-week range||$369.03 - $474.69|
|50-day moving average||$441.84|
|200-day moving average||$422.43|
|Wall St. target price||$489.14|
|Dividend yield||$2.575 (0.56%)|
|Earnings per share (TTM)||$28.15|
Buy Humana shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Humana stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Humana price performance over time
|1 week (2021-07-13)||N/A|
|1 month (2021-06-24)||-3.27%|
|3 months (2021-04-23)||-4.97%|
|6 months (2021-01-20)||N/A|
|1 year (2020-07-20)||N/A|
|2 years (2019-07-20)||N/A|
|3 years (2018-07-20)||N/A|
|5 years (2016-07-20)||N/A|
Is Humana under- or over-valued?
Valuing Humana stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Humana's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Humana's P/E ratio
Humana's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 16x. In other words, Humana shares trade at around 16x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Humana's PEG ratio
Humana's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6159. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Humana's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Humana's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $5.4 billion.
The EBITDA is a measure of a Humana's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$78.9 billion|
|Operating margin TTM||6.51%|
|Gross profit TTM||$15.5 billion|
|Return on assets TTM||8.91%|
|Return on equity TTM||28.04%|
|Market capitalisation||$59.8 billion|
TTM: trailing 12 months
Shorting Humana shares
There are currently 1.1 million Humana shares held short by investors – that's known as Humana's "short interest". This figure is 33.9% down from 1.6 million last month.
There are a few different ways that this level of interest in shorting Humana shares can be evaluated.
Humana's "short interest ratio" (SIR)
Humana's "short interest ratio" (SIR) is the quantity of Humana shares currently shorted divided by the average quantity of Humana shares traded daily (recently around 874311.38211382). Humana's SIR currently stands at 1.23. In other words for every 100,000 Humana shares traded daily on the market, roughly 1230 shares are currently held short.
However Humana's short interest can also be evaluated against the total number of Humana shares, or, against the total number of tradable Humana shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Humana's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Humana shares in existence, roughly 10 shares are currently held short) or 0.0084% of the tradable shares (for every 100,000 tradable Humana shares, roughly 8 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Humana.
Find out more about how you can short Humana stock.
Humana's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Humana.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Humana's total ESG risk score
Total ESG risk: 25.71
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Humana's overall score of 25.71 (as at 12/31/2018) is pretty good – landing it in it in the 33rd percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Humana is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Humana's environmental score
Environmental score: 2.6/100
Humana's environmental score of 2.6 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Humana's social score
Social score: 18.54/100
Humana's social score of 18.54 puts it squarely in the 3rd percentile of companies rated in the same sector. This could suggest that Humana is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Humana's governance score
Governance score: 5.07/100
Humana's governance score puts it squarely in the 3rd percentile of companies rated in the same sector. That could suggest that Humana is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Humana's controversy score
Controversy score: 2/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Humana scored a 2 out of 5 for controversy – the second-highest score possible, reflecting that Humana has, for the most part, managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||25.71|
|Total ESG percentile||32.96|
|Environmental score percentile||3|
|Social score percentile||3|
|Governance score percentile||3|
|Level of controversy||2|
Humana share dividends
Dividend payout ratio: 12.61% of net profits
Recently Humana has paid out, on average, around 12.61% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.6% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Humana shareholders could enjoy a 0.6% return on their shares, in the form of dividend payments. In Humana's case, that would currently equate to about $2.575 per share.
While Humana's payout ratio might seem low, this can signify that Humana is investing more in its future growth.
Humana's most recent dividend payout was on 29 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").
Have Humana's shares ever split?
Humana's shares were split on a 3:2 basis on 31 July 1991. So if you had owned 2 shares the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your Humana shares – just the quantity. However, indirectly, the new 33.3% lower share price could have impacted the market appetite for Humana shares which in turn could have impacted Humana's share price.
Humana share price volatility
Over the last 12 months, Humana's shares have ranged in value from as little as $369.0291 up to $474.6919. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Humana's is 0.8857. This would suggest that Humana's shares are less volatile than average (for this exchange).
Humana Inc. , together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties.
Stocks similar to Humana
Humana in the news
Analysts Estimate Humana (HUM) to Report a Decline in Earnings: What to Look Out for
Will Humana Stock Continue Its Rally After A 10% Rise In A Month?
Noteworthy Tuesday Option Activity: HUM, DISH, GILD
Frequently asked questionsWhat percentage of Humana is owned by insiders or institutions?
Currently 0.24% of Humana shares are held by insiders and 94.653% by institutions. How many people work for Humana?
Latest data suggests 43,000 work at Humana. When does the fiscal year end for Humana?
Humana's fiscal year ends in December. Where is Humana based?
Humana's address is: Humana Building, Louisville, KY, United States, 40202 What is Humana's ISIN number?
Humana's international securities identification number is: US4448591028 What is Humana's CUSIP number?
Humana's Committee on Uniform Securities Identification Procedures number is: 444859102
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy Hellenic Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert